[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

KR850001732A - 소염작용 및 점액 용해작용을 갖는 ⅳ-아세틸시스테인 및 s-카르복시메틸시스테인의 2',4'-디플루오로-4-히드록시-(1,1'-디페닐)-3-카르복실산 유도체의 제조방법 - Google Patents

소염작용 및 점액 용해작용을 갖는 ⅳ-아세틸시스테인 및 s-카르복시메틸시스테인의 2',4'-디플루오로-4-히드록시-(1,1'-디페닐)-3-카르복실산 유도체의 제조방법 Download PDF

Info

Publication number
KR850001732A
KR850001732A KR1019840004727A KR840004727A KR850001732A KR 850001732 A KR850001732 A KR 850001732A KR 1019840004727 A KR1019840004727 A KR 1019840004727A KR 840004727 A KR840004727 A KR 840004727A KR 850001732 A KR850001732 A KR 850001732A
Authority
KR
South Korea
Prior art keywords
difluoro
diphenyl
triethylamine
carboxylic acid
cysteine
Prior art date
Application number
KR1019840004727A
Other languages
English (en)
Other versions
KR920000374B1 (ko
Inventor
세트바이 귀도
Original Assignee
원본미기재
라보라토리 귀도티 에스. 피. 에이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 라보라토리 귀도티 에스. 피. 에이 filed Critical 원본미기재
Publication of KR850001732A publication Critical patent/KR850001732A/ko
Application granted granted Critical
Publication of KR920000374B1 publication Critical patent/KR920000374B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

소염작용 및 점액 용해작용을 갖는 Ⅳ-아세틸시스테인 및 S-카르복시메틸시스테인의 2',4'-디플루오로-4-히드록시-(1,1'-디페닐)-3-카르복실산 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (8)

  1. 2',4'-디플루오로-4-히드록시-(1,1'-디페닐)-3-카르복실산을 알킬클로로카르보네이트와 반응시켜서 대응하는 혼합 무수물로 전환시키고, 이어서 이 혼합무수물을 N-아세틸 시스테인과 반응시켜서 O-알킬카르보네이트 티오에스테르로 전환시킨 다음에 수소화시킴을 특징으로 하는 다음 일반식(Ⅰ)으로 표시되는 N-아세틸 시스테인 및 S-카르복시메틸 시스테인의 2',4'-디플루오로-4-히드록시-(1,1'-디페닐)-3-카르복실산 유도체의 제조방법.
    위의 일반식(Ⅰ)에서, R은 H-CDCH3-COOC2H5-COOCH2-CCl3이고, R'는 -S-임.
  2. 제1항에서, 알킬클로로카르보이트가 2,2,2-트리클로로에틸-클로로카르보네이트 또는 에틸클로로카르보네이트이고, 혼합 무수물 제조 반응을 산 수용체 존재하에서 행함을 특징으로 하는 방법.
  3. 제2항에서, 산 수용체가 트리에틸아민인 것을 특징으로 하는 방법.
  4. 제1항에서, 혼합 무수물 제조 반응을 산수용체 존재하에서 행함을 특징으로 하는 방법.
  5. 제2항에서, 산수용체가 트리에틸아민인 것을 특징으로 하는 방법.
  6. 제1항에서, 혼합 무수물 제조 반응을 과량의 알킬클로로카르보네이트와 트리에틸아민 존재하에서 행하고, 이 혼합 무수물을 단리시킨 다음에 트리에틸아민 존재하에서 N-아세틸-L-시스테인과 반응시킨 후에, 이어서 과량의 트리에틸아민을 첨가하고, 목적 화합물을 수소화시킬 필요없이 트리에틸아민염의 형태로 얻는 것을 특징으로 하는 방법.
  7. 2',4'-디플루오로-4-아세톡시-(1,1'-디페닐)-3-카르복실산을 디시클로헥실카르보디이미드 존재하에 S-카르복시메틸시스테인인 디메틸에스테르와 함께 응축시키고, 이 생성물을 알칼리성 가수분해시킴을 특징으로 하는 일반식(Ⅰ)으로 표시되는 N-[2',4'-디플루오로-4-히드록시-(1,1'-디페닐)-카르보닐-S-카르복시-메틸시스테인의 제조방법.
    위의 일반식(Ⅰ)에서, R은 H-COCH3-COOC2H5-COOCH2-CCl3이고, R'는 -NH-임.
  8. 2',4'-디플루오로-4-아세톡시-(1,1'-디페닐)-3-카르복실산을 대응하는 산염화물로 전환시키고 이어서 이 산염화물을 N-아세틸-L-시스테인과 반응시킴을 특징으로 하는 일반식(Ⅰ)으로 표시되는 S-[2',4'-디플루오로-4-아세톡시-(1,1'-디페닐)-카르보닐]-N-아세틸-L-시스테인의 제조방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840004727A 1983-08-09 1984-08-08 소염작용 및 점액 용해작용을 갖는 n-아세틸 시스테인 및 s-카르복시메틸시스테인의 2',4'-디플루오로-4-히드록시-(1,1'-디페닐)-3-카르복실산 유도체의 제조방법 KR920000374B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8322486A IT1206515B (it) 1983-08-09 1983-08-09 N-acetilcisteina ederivati 2',4's-carbossimetilcisteina ad-difluoro-4-idrossi-(1,1'-bifenil)attivita' antinfiammatoria, 3-carbossilici della mucolitica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
IT22486A/83 1983-08-09

Publications (2)

Publication Number Publication Date
KR850001732A true KR850001732A (ko) 1985-04-01
KR920000374B1 KR920000374B1 (ko) 1992-01-13

Family

ID=11196917

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840004727A KR920000374B1 (ko) 1983-08-09 1984-08-08 소염작용 및 점액 용해작용을 갖는 n-아세틸 시스테인 및 s-카르복시메틸시스테인의 2',4'-디플루오로-4-히드록시-(1,1'-디페닐)-3-카르복실산 유도체의 제조방법

Country Status (9)

Country Link
EP (1) EP0144519B1 (ko)
JP (1) JPS6067458A (ko)
KR (1) KR920000374B1 (ko)
AT (1) ATE27699T1 (ko)
BE (1) BE900328A (ko)
DE (1) DE3464134D1 (ko)
ES (1) ES8602640A1 (ko)
FR (1) FR2550530B1 (ko)
IT (1) IT1206515B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0912716A2 (pt) * 2008-05-13 2015-10-13 Genmedica Therapeutics Sl composto.
WO2010106082A1 (en) 2009-03-16 2010-09-23 Genmedica Therapeutics Sl Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
CN102421424A (zh) * 2009-03-16 2012-04-18 根梅迪卡治疗公司 用于治疗代谢性疾病的组合疗法
US8466197B2 (en) 2010-12-14 2013-06-18 Genmedica Therapeutics Sl Thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders
WO2013037984A1 (en) 2011-09-16 2013-03-21 Genmedica Therapeutics Sl Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
CA2847915A1 (en) 2011-09-16 2013-03-21 Genmedica Therapeutics Sl Pharmaceutical combinations including anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2068398B2 (ko) * 1969-10-07 1973-01-12 Rech Pharmac Scientif
BE794952A (fr) * 1972-02-03 1973-08-02 Bristol Myers Co N-acetyl-l-cysteinate d'ammonium et procede pour le preparer
IT1194117B (it) * 1981-11-20 1988-09-14 Isnardi Pietro & C Spa Derivati salicilici di n-acetilcisteina

Also Published As

Publication number Publication date
ES534958A0 (es) 1985-12-16
EP0144519B1 (en) 1987-06-10
JPH051788B2 (ko) 1993-01-11
ES8602640A1 (es) 1985-12-16
FR2550530A1 (fr) 1985-02-15
EP0144519A1 (en) 1985-06-19
DE3464134D1 (en) 1987-07-16
BE900328A (fr) 1984-12-03
JPS6067458A (ja) 1985-04-17
IT8322486A0 (it) 1983-08-09
FR2550530B1 (fr) 1987-01-23
ATE27699T1 (de) 1987-06-15
KR920000374B1 (ko) 1992-01-13
IT1206515B (it) 1989-04-27

Similar Documents

Publication Publication Date Title
KR940014440A (ko) 수용액에서의 치환도가 중간인 전분에스테르 및 그 제조방법
AU5735586A (en) Oligopeptide derivatives, their production and their use as surfactantes kind to the skin
KR920701143A (ko) S-저급지방산 글루타티온 유도체
KR850001732A (ko) 소염작용 및 점액 용해작용을 갖는 ⅳ-아세틸시스테인 및 s-카르복시메틸시스테인의 2',4'-디플루오로-4-히드록시-(1,1'-디페닐)-3-카르복실산 유도체의 제조방법
TW328948B (en) Composition and process for the synthesis of oxysulphide-containing fluorine-containing organic derivatives
KR910002865A (ko) 피라노벤즈옥사디아졸 화합물 및 그 광학적 분할방법
KR860004010A (ko) N-[6-메톡시-5-(퍼플루오로알킬)-1-나프토일]-n-메틸글리신 및 이의 티오프토일 동족체의 제조방법
KR860001045A (ko) 메발로노락톤의 나프틸 동족체의 제조방법
KR850001724A (ko) 4-페닐-4-옥소-부텐-2-오인산유도체의 제조방법
KR850001766A (ko) 무라밀디펩타이드 활성 에스테르 유도체의 제조방법
KR870003078A (ko) N-설파밀-3-(2-구아니디노-티아졸-4-일-메틸티오)프로피온아미딘의 제조방법
KR900018032A (ko) 2,3-디클로로-5-아세틸피리딘의 제조방법
KR880012762A (ko) (r)-3-클로로-1,2-프로판디올의 제조방법
SE8205563D0 (sv) Process for the preparation of vincaminic acid esters
KR840002344A (ko) 4-[n-(하이드록시벤질)아미노메틸] 사이클로헥산-1-카복실산의 제조방법
GB1338802A (en) Nail varnishes
KR840009110A (ko) 알파-아미노 벤질 페니실린의 에스테르 화합물의 제조방법
ATE55372T1 (de) Verfahren zur herstellung von 4-chlorbutanalen.
KR840006227A (ko) 5-티오-1,2,3-티아디아졸의 합성법
KR840007591A (ko) 니자티딘의 합성법
KR890002178A (ko) 신규한 세펨 화합물
KR850008493A (ko) N-포르밀-디티오포스폰산 아미드의 제조방법
KR840009111A (ko) 알파-아미노 엠질 페니실린의 에스테르 화합물의 제조방법
KR830002696A (ko) N-(2-프로피닐)-카바닐린산(3-지방성탄화수소-옥시-또는 티오-카보닐아미노페닐) 에스테르의 제조방법
KR850008670A (ko) 약학적특성의 신규아실아미노페놀 유도체의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee